211 related articles for article (PubMed ID: 29337401)
1. Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactions.
Deljehier T; Pariente A; Miremont-Salamé G; Haramburu F; Nguyen L; Rubin S; Rigothier C; Théophile H
Br J Clin Pharmacol; 2018 May; 84(5):1057-1063. PubMed ID: 29337401
[TBL] [Abstract][Full Text] [Related]
2. Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin.
Magee CN; Medani SA; Leavey SF; Conlon PJ; Clarkson MR
Am J Kidney Dis; 2010 Nov; 56(5):e11-5. PubMed ID: 20888103
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyolysis with atorvastatin and fusidic acid.
O'Mahony C; Campbell VL; Al-Khayatt MS; Brull DJ
Postgrad Med J; 2008 Jun; 84(992):325-7. PubMed ID: 18644925
[TBL] [Abstract][Full Text] [Related]
4. Fatal rhabdomyolysis following the co-prescription of fusidic acid and pravastatin.
Bachoumas K; Fiancette M; Lascarrou JB; Lacherade JC; Leclair F; Reignier J
Med Mal Infect; 2015 Oct; 45(10):417-9. PubMed ID: 26472060
[No Abstract] [Full Text] [Related]
5. [Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid].
Gabignon C; Zeller V; Le Guyader N; Desplaces N; Lidove O; Ziza JM
Rev Med Interne; 2013 Jan; 34(1):39-41. PubMed ID: 23102978
[TBL] [Abstract][Full Text] [Related]
6. A timely reminder about the concomitant use of fusidic acid with statins.
Cowan R; Johnson PD; Urbancic K; Grayson ML
Clin Infect Dis; 2013 Jul; 57(2):329-30. PubMed ID: 23588554
[No Abstract] [Full Text] [Related]
7. Muscle Damage Due to Fusidic Acid-Statin Interaction: Review of 75 Cases From the French Pharmacovigilance Database and Literature Reports.
Bataillard M; Beyens MN; Mounier G; Vergnon-Miszczycha D; Bagheri H; Cathebras P
Am J Ther; 2019; 26(3):e375-e379. PubMed ID: 29189310
[TBL] [Abstract][Full Text] [Related]
8. Severe statin-induced rhabdomyolysis mimicking Guillain-Barré syndrome in four patients with diabetes mellitus treated with fusidic acid.
Collidge TA; Razvi S; Nolan C; Whittle M; Stirling C; Russell AJ; Mann AC; Deighan CJ
Diabet Med; 2010 Jun; 27(6):696-700. PubMed ID: 20546290
[TBL] [Abstract][Full Text] [Related]
9. Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.
Wenisch C; Krause R; Fladerer P; El Menjawi I; Pohanka E
Am J Med; 2000 Jul; 109(1):78. PubMed ID: 10991749
[No Abstract] [Full Text] [Related]
10. Presumed interaction of fusidic acid with simvastatin.
Burtenshaw AJ; Sellors G; Downing R
Anaesthesia; 2008 Jun; 63(6):656-8. PubMed ID: 18477279
[TBL] [Abstract][Full Text] [Related]
11. Rhabdomyolysis following co-prescription of fusidic acid and atorvastatin.
Teckchandani S; Robertson S; Almond A; Donaldson K; Isles C
J R Coll Physicians Edinb; 2010 Mar; 40(1):33-6. PubMed ID: 21125037
[TBL] [Abstract][Full Text] [Related]
12. Rhabdomyolysis after co-prescription of statin and fusidic acid.
Kearney S; Carr AS; McConville J; McCarron MO;
BMJ; 2012 Oct; 345():e6562. PubMed ID: 23047962
[No Abstract] [Full Text] [Related]
13. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
Chang JT; Staffa JA; Parks M; Green L
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
[TBL] [Abstract][Full Text] [Related]
14. Rhabdomyolysis secondary to interaction of fusidic acid and simvastatin.
Yuen SL; McGarity B
Med J Aust; 2003 Aug; 179(3):172. PubMed ID: 12885276
[No Abstract] [Full Text] [Related]
15. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports.
Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P
Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302
[TBL] [Abstract][Full Text] [Related]
16. Incidence of hospitalized rhabdomyolysis with statin and fibrate use in an insured US population.
Amend KL; Landon J; Thyagarajan V; Niemcryk S; McAfee A
Ann Pharmacother; 2011 Oct; 45(10):1230-9. PubMed ID: 21917557
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of drug-associated rhabdomyolysis: analysis of 8,610 cases reported to the U.S. Food and Drug Administration.
Oshima Y
Intern Med; 2011; 50(8):845-53. PubMed ID: 21498932
[TBL] [Abstract][Full Text] [Related]
18. Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction.
Strandell J; Bate A; Hägg S; Edwards IR
Br J Clin Pharmacol; 2009 Sep; 68(3):427-34. PubMed ID: 19740401
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for rhabdomyolysis with HMG-CoA reductase inhibitors identified using a postmarketing surveillance database in Japan
.
Hashiguchi M; Hakamata J; Shimizu M; Maruyama J; Shiga T; Mochizuki M
Int J Clin Pharmacol Ther; 2018 Jul; 56(7):310-320. PubMed ID: 29701171
[TBL] [Abstract][Full Text] [Related]
20. Severe Rhabdomyolysis as Complication of Interaction between Atorvastatin and Fusidic Acid in a Patient in Lifelong Antibiotic Prophylaxis: A Dangerous Combination.
Nandy A; Gaïni S
Case Rep Med; 2016; 2016():4705492. PubMed ID: 28115938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
